Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Colorectal cancer detection by biomarker quantification in noninvasively collected colorectal mucus: preliminary comparison of 24 protein biomarkers.

Loktionov A, Soubieres A, Bandaletova T, Mathur J, Poullis A.

Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1220-1227. doi: 10.1097/MEG.0000000000001535.

PMID:
31498281
2.

Challenges in the management of pancreatic exocrine insufficiency.

Shandro BM, Nagarajah R, Poullis A.

World J Gastrointest Pharmacol Ther. 2018 Oct 25;9(5):39-46. doi: 10.4292/wjgpt.v9.i5.39.

3.

Gastrointestinal Symptoms in Marfan Syndrome and Hypermobile Ehlers-Danlos Syndrome.

Inayet N, Hayat JO, Kaul A, Tome M, Child A, Poullis A.

Gastroenterol Res Pract. 2018 Jul 29;2018:4854701. doi: 10.1155/2018/4854701. eCollection 2018.

4.

Health concerns associated with travelling with inflammatory bowel disease (IBD): a questionnaire survey.

Philip V, Soubieres A, Poullis A.

Clin Med (Lond). 2018 Aug;18(4):288-292. doi: 10.7861/clinmedicine.18-4-288.

5.

Reply.

Soubieres AA, Poullis A.

Inflamm Bowel Dis. 2017 Jan;23(1):E1. doi: 10.1097/MIB.0000000000000983. No abstract available.

PMID:
28002132
6.

Effects of eosinophilic oesophagitis on quality of life in an adult UK population: a case control study.

Hewett R, Alexakis C, Farmer AD, Ainley J, Chhaya V, Hayat JO, Poullis A, Kang JY.

Dis Esophagus. 2017 Jan 1;30(1):1-7. doi: 10.1111/dote.12524.

PMID:
27868307
7.

Inflammatory bowel disease detection and monitoring by measuring biomarkers in non-invasively collected colorectal mucus.

Loktionov A, Chhaya V, Bandaletova T, Poullis A.

J Gastroenterol Hepatol. 2017 May;32(5):992-1002. doi: 10.1111/jgh.13627.

PMID:
27787913
8.

Abdominal tuberculosis: Diagnosis and demographics, a 10-year retrospective review from a single centre.

Nayagam JS, Mullender C, Cosgrove C, Poullis A.

World J Clin Cases. 2016 Aug 16;4(8):207-12. doi: 10.12998/wjcc.v4.i8.207.

9.

Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases.

Soubières AA, Poullis A.

Inflamm Bowel Dis. 2016 Aug;22(8):2016-22. doi: 10.1097/MIB.0000000000000836. Review.

PMID:
27416044
10.

Eosinophilic oesophagitis.

Bancil AS, Hewett R, Hayat JO, Poullis A.

Br J Hosp Med (Lond). 2016 Jul;77(7):409-13. doi: 10.12968/hmed.2016.77.7.409. Review.

PMID:
27388380
11.

Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease.

Soubières AA, Poullis A.

World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):41-50. doi: 10.4292/wjgpt.v7.i1.41. Review.

12.

Colorectal mucus non-invasively collected from patients with inflammatory bowel disease and its suitability for diagnostic cytology.

Bandaletova T, Chhaya V, Poullis A, Loktionov A.

APMIS. 2016 Mar;124(3):160-8. doi: 10.1111/apm.12479. Epub 2015 Nov 20.

PMID:
26589885
13.

Differences in intestinal metaplasia in Barrett's esophagus patients in an ethnically diverse south London population.

Hewett R, Chhaya V, Chan D, Kang JY, Poullis A.

Indian J Gastroenterol. 2015 Sep;34(5):399-403. doi: 10.1007/s12664-015-0597-9. Epub 2015 Nov 5.

PMID:
26541341
14.

Burden of irritable bowel syndrome in an increasingly cost-aware National Health Service.

Soubieres A, Wilson P, Poullis A, Wilkins J, Rance M.

Frontline Gastroenterol. 2015 Oct;6(4):246-251. doi: 10.1136/flgastro-2014-100542. Epub 2015 Feb 24.

15.

Assessment of cytology and mucin 2 in colorectal mucus collected from patients with inflammatory bowel disease: Results of a pilot trial.

Loktionov A, Chhaya V, Bandaletova T, Poullis A.

J Gastroenterol Hepatol. 2016 Feb;31(2):326-33. doi: 10.1111/jgh.13083.

PMID:
26248500
16.

Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis.

Fleming K, Ashcroft A, Alexakis C, Tzias D, Groves C, Poullis A.

World J Gastroenterol. 2015 Mar 21;21(11):3376-9. doi: 10.3748/wjg.v21.i11.3376.

17.

Inflammatory bowel disease in young patients: challenges faced by black and minority ethnic communities in the UK.

Alexakis C, Nash A, Lloyd M, Brooks F, Lindsay JO, Poullis A.

Health Soc Care Community. 2015 Nov;23(6):665-72. doi: 10.1111/hsc.12188. Epub 2015 Feb 9.

PMID:
25660726
18.

New Barrett's oesophagus surveillance guidelines: significant cost savings over the next 10 years on implementation.

Hewett R, Chan D, Kang JY, Poullis A.

Frontline Gastroenterol. 2015 Jan;6(1):6-10. doi: 10.1136/flgastro-2014-100478. Epub 2014 Jun 30.

19.

The Role of Vitamin D in Inflammatory Bowel Disease.

Bancil AS, Poullis A.

Healthcare (Basel). 2015 May 27;3(2):338-50. doi: 10.3390/healthcare3020338. Review.

20.

The Cost Of Irritable Bowel Syndrome (Ibs) In England.

Soubieres A, Wilson P, Poullis A, Wilkins J, Rance M.

Value Health. 2014 Nov;17(7):A365. doi: 10.1016/j.jval.2014.08.813. Epub 2014 Oct 26. No abstract available.

21.

Comment on 'Reasons for non-uptake and subsequent participation in the NHS bowel cancer screening programme: a qualitative study'.

Tai CK, Leung P, Poullis A, Curry G.

Br J Cancer. 2015 May 26;112(11):1834. doi: 10.1038/bjc.2014.559. Epub 2014 Nov 4. No abstract available.

22.

Perspectives and attitudes of young patients with inflammatory bowel disease: symptoms, burden of disease and communication with their healthcare professionals.

Alexakis C, Davies G, Stephens J, Clark S, Rogers S, Poullis A.

Frontline Gastroenterol. 2014 Jul;5(3):197-202. doi: 10.1136/flgastro-2013-100400. Epub 2013 Dec 13.

23.

Social media use in patients with inflammatory bowel disease and chronic viral hepatitis.

Timms C, Forton DM, Poullis A.

Clin Med (Lond). 2014 Apr;14(2):215. doi: 10.7861/clinmedicine.14-2-215. No abstract available.

24.

Inflammatory bowel disease and exercise: results of a Crohn's and Colitis UK survey.

Chan D, Robbins H, Rogers S, Clark S, Poullis A.

Frontline Gastroenterol. 2014 Jan;5(1):44-48. doi: 10.1136/flgastro-2013-100339. Epub 2013 Jul 31.

25.

Temporal trends in imaging and associated radiation exposure in inflammatory bowel disease.

Chatu S, Poullis A, Holmes R, Greenhalgh R, Pollok RC.

Int J Clin Pract. 2013 Oct;67(10):1057-65. doi: 10.1111/ijcp.12187.

PMID:
24073979
26.

Factors associated with vitamin D deficiency in a multicultural inflammatory bowel disease cohort.

Chatu S, Chhaya V, Holmes R, Neild P, Kang JY, Pollok RC, Poullis A.

Frontline Gastroenterol. 2013 Jan;4(1):51-56. doi: 10.1136/flgastro-2012-100231. Epub 2012 Oct 31.

27.

Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.

Alexandropoulou K, van Vlymen J, Reid F, Poullis A, Kang JY.

Eur J Gastroenterol Hepatol. 2013 Jan;25(1):15-21. doi: 10.1097/MEG.0b013e3283595086.

PMID:
23022985
28.

Eosinophilic oesophagitis: a clinical update.

Hayat JO, Alexandropoulou K, Poullis AP, Kang JY.

Br J Gen Pract. 2012 Sep;62(602):499-500. doi: 10.3399/bjgp12X654768. No abstract available.

29.

Sub-optimal H1N1 vaccine uptake by immunocompromised inflammatory bowel disease patients.

Hanna M, Poullis A.

Clin Med (Lond). 2011 Jun;11(3):301. No abstract available.

30.

Nutrition support in intensive care units in England: a snapshot of present practice.

Sharifi MN, Walton A, Chakrabarty G, Rahman T, Neild P, Poullis A.

Br J Nutr. 2011 Oct;106(8):1240-4. doi: 10.1017/S0007114511001619. Epub 2011 May 31.

PMID:
21736813
31.

Uncomplicated diverticular disease is not a common cause of colonic symptoms.

Kang JY, Firwana B, Green AE, Matthews H, Poullis A, Barnabas A, Tan LT, Lim AG.

Aliment Pharmacol Ther. 2011 Feb;33(4):487-94. doi: 10.1111/j.1365-2036.2010.04540.x. Epub 2010 Dec 16.

32.

Methodological study on repeat single photon computerized tomography white cell scanning to monitor efficacy of treatment in inflammatory bowel disease.

Poullis A, Irwin A, Dearing M, Britten A, Vennart W, Heenan S.

Eur J Gastroenterol Hepatol. 2010 Dec;22(12):1506-7. doi: 10.1097/MEG.0b013e32833fac5b. No abstract available.

PMID:
21048464
33.

Apoptosis in the colonic crypt, colorectal adenomata, and manipulation by chemoprevention.

West NJ, Courtney ED, Poullis AP, Leicester RJ.

Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1680-7. doi: 10.1158/1055-9965.EPI-09-0006. Review.

34.

Clopidogrel. More on proton pump inhibitors.

Sadler GJ, Poullis AP.

BMJ. 2009 May 20;338:b1931. doi: 10.1136/bmj.b1931. No abstract available.

PMID:
19457956
35.

Differences in frequency of colonic polyps in different ethnic groups in the United Kingdom.

West NJ, Leicester RJ, Kang JY, Poullis AP.

Indian J Gastroenterol. 2007 Jul-Aug;26(4):194-5. No abstract available.

PMID:
17986757
36.

The NHS Bowel Cancer Screening Programme--a realistic approach with additional benefits.

West NJ, Poullis AP, Leicester RJ.

Colorectal Dis. 2008 Sep;10(7):708-14. Epub 2007 Oct 23.

PMID:
17956587
37.

Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people.

John BJ, Abulafi AM, Poullis A, Mendall MA.

Gut. 2007 Jul;56(7):1034-5. No abstract available.

38.

Mesalazine-induced bronchiectasis and eosinophilia in a patient with ulcerative colitis: a case report.

Price LC, Poullis A, Grubnic S, Kang JY, Rayner CF.

J R Soc Med. 2007 Mar;100(3):151-2. No abstract available.

39.

Systematic review: does gastro-oesophageal reflux disease progress?

Fullard M, Kang JY, Neild P, Poullis A, Maxwell JD.

Aliment Pharmacol Ther. 2006 Jul 1;24(1):33-45. Review.

40.

Repeat planar white cell scanning to monitor short-term therapy of active inflammatory bowel disease: a methodological study and comparison with clinical scores and novel inflammatory markers.

Poullis A, Irwin AG, Dearing M, Gordon C, Britten AJ, Heenan S, Maxwell JD.

Eur J Gastroenterol Hepatol. 2006 Jun;18(6):607-14.

PMID:
16702849
41.

White cell scanning has a role in imaging small and large bowel.

Poullis AP.

Gut. 2006 Jun;55(6):903. No abstract available.

42.

Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk.

Poullis A, Foster R, Shetty A, Fagerhol MK, Mendall MA.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):279-84.

43.

Effect of the CD14 promoter polymorphism on liver function tests and its association with alcohol and obesity.

Poullis AP, Shetty AK, Risley PD, Collinson PO, Mendall MA.

Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1317-22.

PMID:
14624155
44.

Routine transferrin saturation measurement in liver clinic patients increases detection of hereditary haemochromatosis.

Poullis A, Moodie SJ, Ang L, Finlayson CJ, Levin GE, Maxwell JD.

Ann Clin Biochem. 2003 Sep;40(Pt 5):521-7.

PMID:
14503989
45.

Emerging role of calprotectin in gastroenterology.

Poullis A, Foster R, Mendall MA, Fagerhol MK.

J Gastroenterol Hepatol. 2003 Jul;18(7):756-62. Review.

PMID:
12795745
46.

Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity.

Poullis A, Foster R, Mendall MA, Shreeve D, Wiener K.

Eur J Gastroenterol Hepatol. 2003 May;15(5):573-4; author reply 574. No abstract available.

PMID:
12702920
47.

Clinical haemochromatosis in HFE mutation carriers.

Poullis A, Moodie SJ, Maxwell JD.

Lancet. 2002 Aug 3;360(9330):411-2; author reply 413-4. No abstract available.

PMID:
12241803
48.

A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders.

Poullis AP, Zar S, Sundaram KK, Moodie SJ, Risley P, Theodossi A, Mendall MA.

Eur J Gastroenterol Hepatol. 2002 Apr;14(4):409-12.

PMID:
11943955
49.

Review article: faecal markers in the assessment of activity in inflammatory bowel disease.

Poullis A, Foster R, Northfield TC, Mendall MA.

Aliment Pharmacol Ther. 2002 Apr;16(4):675-81. Review.

50.

Ascitic fluid analysis: the role of imaging.

Poullis A.

Hosp Med. 2001 Aug;62(8):511. No abstract available.

PMID:
11530598

Supplemental Content

Loading ...
Support Center